
About The Cover
The cover for issue 21 of Oncotarget features Figure 7, "OSM and IL-1β promote IL-6 expression in a breast cancer cell-subtype specific manner," by Tawara, et al.
Table of Contents
Editorial
The use of protein phosphatase 2A activators in combination therapies for pancreas cancer
The use of protein phosphatase 2A activators in combination therapies for pancreas cancer |
https://doi.org/10.18632/oncotarget.26772 Brittany L. Allen-Petersen, and Rosalie C. Sears |
2008-2009 |
PDF | How to cite |
TET2 mutations and clonal dynamics
TET2 mutations and clonal dynamics |
https://doi.org/10.18632/oncotarget.26779 Ashwin Kishtagari, Babal K. Jha, and Jaroslaw P. Maciejewski |
2010-2011 |
PDF | How to cite |
Research Papers
Next generation sequencing driven successful combined treatment with laparoscopic surgery and immunotherapy for relapsed stage IVB cervical and synchronous stage IV lung cancer
Next generation sequencing driven successful combined treatment with laparoscopic surgery and immunotherapy for relapsed stage IVB cervical and synchronous stage IV lung cancer |
https://doi.org/10.18632/oncotarget.26769 Clelia Madeddu, Paraskevas Kotsonis, Fabrizio Lavra, Giacomo Chiappe, Luca Melis, Ester Mura, Mario Scartozzi, and Antonio Macciò |
2012-2021 |
Abstract | PDF | Full Text | Supplementary Information | How to cite |
Multi-walled carbon nanotubes complement the anti-tumoral effect of 5-Fluorouracil
Multi-walled carbon nanotubes complement the anti-tumoral effect of 5-Fluorouracil |
https://doi.org/10.18632/oncotarget.26770 Eloisa González-Lavado, Lourdes Valdivia, Almudena García-Castaño, Fernando González, Carmen Pesquera, Rafael Valiente, and Mónica L. Fanarraga |
2022-2029 |
Abstract | PDF | Full Text | Supplementary Information | How to cite |
The immune checkpoint molecules PD-1, PD-L1, TIM-3 and LAG-3 in diffuse large B-cell lymphoma
The immune checkpoint molecules PD-1, PD-L1, TIM-3 and LAG-3 in diffuse large B-cell lymphoma |
https://doi.org/10.18632/oncotarget.26771 Benjamin J. Chen, Ravi Dashnamoorthy, Pallavi Galera, Vladislav Makarenko, Hong Chang, Srimoyee Ghosh, and Andrew M. Evens |
2030-2040 |
Abstract | PDF | Full Text | How to cite |
CD164 regulates proliferation, progression, and invasion of human glioblastoma cells
CD164 regulates proliferation, progression, and invasion of human glioblastoma cells |
https://doi.org/10.18632/oncotarget.26724 Chung-Ching Wang, Dueng-Yuan Hueng, Ai-Fang Huang, Wei-Liang Chen, Shih-Ming Huang, and James Yi-Hsin Chan |
2041-2054 |
Abstract | PDF | Full Text | Supplementary Information | How to cite |
AXL knockdown gene signature reveals a drug repurposing opportunity for a class of antipsychotics to reduce growth and metastasis of triple negative breast cancer
AXL knockdown gene signature reveals a drug repurposing opportunity for a class of antipsychotics to reduce growth and metastasis of triple negative breast cancer |
https://doi.org/10.18632/oncotarget.26725 Marie-Anne Goyette, Rebecca Cusseddu, Islam Elkholi, Afnan Abu-Thuraia, Nehme El-Hachem, Benjamin Haibe-Kains, Jean-Philippe Gratton, and Jean-François Côté |
2055-2067 |
Abstract | PDF | Full Text | Supplementary Information | How to cite |
HIGH expression of OSM and IL-6 are associated with decreased breast cancer survival: synergistic induction of IL-6 secretion by OSM and IL-1β
HIGH expression of OSM and IL-6 are associated with decreased breast cancer survival: synergistic induction of IL-6 secretion by OSM and IL-1β |
https://doi.org/10.18632/oncotarget.26699 Ken Tawara, Hannah Scott, Jacqueline Emathinger, Cody Wolf, Dollie LaJoie, Danielle Hedeen, Laura Bond, Paul Montgomery, and Cheryl Jorcyk |
2068-2085 |
Abstract | PDF | Full Text | Supplementary Information | How to cite |
Dual inhibition of ABCE1 and LCP1 by microRNA-96 results in an additive effect in breast cancer mouse model
Dual inhibition of ABCE1 and LCP1 by microRNA-96 results in an additive effect in breast cancer mouse model |
https://doi.org/10.18632/oncotarget.26747 Nir Pillar, Avital Luba Polsky, and Noam Shomron |
2086-2094 |
Abstract | PDF | Full Text | Supplementary Information | How to cite |
Reviews
Molecular mechanisms and pathobiology of oncogenic fusion transcripts in epithelial tumors
Molecular mechanisms and pathobiology of oncogenic fusion transcripts in epithelial tumors |
https://doi.org/10.18632/oncotarget.26777 Musaffe Tuna, Christopher I. Amos, and Gordon B. Mills |
2095-2111 |
Abstract | PDF | Full Text | Supplementary Information | How to cite |
Corrections
Correction: HOTAIR regulates HK2 expression by binding endogenous miR-125 and miR-143 in oesophageal squamous cell carcinoma progression
Correction: HOTAIR regulates HK2 expression by binding endogenous miR-125 and miR-143 in oesophageal squamous cell carcinoma progression |
https://doi.org/10.18632/oncotarget.26801 Jian Ma, Yanxin Fan, Tingting Feng, Fangjun Chen, Zhipeng Xu, Suqing Li, Qingfeng Lin, Xiaoting He, Weihong Shi, Yang Liu, Zhihua Liu, Bin Zhu, and Xiufeng Cao |
2112-2112 |
Correction | PDF | How to cite |
Errata
Erratum: Predicting clinically significant prostate cancer using DCE-MRI habitat descriptors
Erratum: Predicting clinically significant prostate cancer using DCE-MRI habitat descriptors |
https://doi.org/10.18632/oncotarget.26802 N. Andres Parra, Hong Lu, Qian Li, Radka Stoyanova, Alan Pollack, Sanoj Punnen, Jung Choi, Mahmoud Abdalah, Christopher Lopez, Kenneth Gage, Jong Y. Park, Yamoah Kosj, Julio M. Pow-Sang, Robert J. Gillies, and Yoganand Balagurunathan |
2113-2113 |
Erratum | PDF | How to cite |
Copyright © 2025 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC